GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed... Published 10 Oct, 2024 11:56am
Markets GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward Shares of British drugmaker GSK dropped more than 9% on Monday, after a Delaware judge allowed more than 70,000... Published 03 Jun, 2024 01:29pm
World GSK soothes investors by settling first Zantac cancer lawsuit due for US trial GSK agreed to settle a US lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British... Published 26 Jun, 2023 11:13am
World Drugmaker settles US Zantac cancer case LONDON: British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged... Published 23 Jun, 2023 06:52pm
World Sanofi says arbitration court rejects Boehringer’s Zantac claims FRANKFURT: Sanofi said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration... Published 20 Jun, 2023 12:10pm
World Judge to weigh key evidence ahead of first Zantac cancer trial GSK Plc is expected to urge a California judge on Thursday to limit what expert testimony jurors can hear in the... Published 17 Feb, 2023 11:26am
World Haleon rejects Zantac indemnification requests from GSK, Pfizer LONDON: Haleon on Tuesday said it had notified GSK and Pfizer that it had rejected their requests for... Published 20 Sep, 2022 12:03pm
Business & Finance Sanofi trial failure halts work on breast cancer treatment amcenestrant Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast... Published 17 Aug, 2022 10:41pm
Markets GSK, Sanofi and Haleon shares slump on Zantac litigation concerns LONDON: Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines earlier this week, amid ... Published 12 Aug, 2022 12:35am